159 related articles for article (PubMed ID: 18064485)
1. Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.
Niedźwiecki S; Stepień T; Kuzdak K; Stepień H; Krupiński R; Seehofer D; Rayes N; Ulrich F
Langenbecks Arch Surg; 2008 May; 393(3):275-80. PubMed ID: 18064485
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of serum Interleukin-1 receptor antagonist levels as a diagnostic and prognostic assay in surgical patients.
Kapoor S
Langenbecks Arch Surg; 2009 Mar; 394(2):401-2; author reply 403. PubMed ID: 18825404
[No Abstract] [Full Text] [Related]
3. Serum cytokeratins determination in differentiated thyroid carcinoma.
Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
[TBL] [Abstract][Full Text] [Related]
4. Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
Hocevar M; Auersperg M
Eur J Surg Oncol; 1998 Dec; 24(6):553-7. PubMed ID: 9870733
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma.
Zhang X; Li S; Wang J; Liu F; Zhao Y
Technol Cancer Res Treat; 2021; 20():1533033821990055. PubMed ID: 33752541
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers.
Lawnicka H; Motylewska E; Borkowska M; Kuzdak K; Siejka A; Swietoslawski J; Stepien H; Stepien T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):77-83. PubMed ID: 31132076
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors].
Kołomecki K; Maciaszczyk P; Stepień H; Cywiński J; Cielecka J; Stepień T; Kuzdak K
Endokrynol Pol; 2006; 57(4):320-5. PubMed ID: 17006831
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
9. Expressions of IL-17 and TNF-α in patients with Hashimoto's disease combined with thyroid cancer before and after surgery and their relationship with prognosis.
Zhang N; Wang Q; Tian Y; Xiong S; Li G; Xu L
Clin Transl Oncol; 2020 Aug; 22(8):1280-1287. PubMed ID: 31873916
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
[TBL] [Abstract][Full Text] [Related]
15. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
16. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
Ito H; Miki C
Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
18. Referral bias in thyroid cancer surgery: direction and magnitude.
Machens A; Hauptmann S; Dralle H
Eur J Surg Oncol; 2008 May; 34(5):556-62. PubMed ID: 17716850
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma.
Fujiwaki R; Iida K; Nakayama K; Kanasaki H; Hata K; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2003 Apr; 89(1):77-83. PubMed ID: 12694657
[TBL] [Abstract][Full Text] [Related]
20. Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule.
Fukushima M; Ito Y; Hirokawa M; Miya A; Kobayashi K; Akasu H; Shimizu K; Miyauchi A
World J Surg; 2009 May; 33(5):963-8. PubMed ID: 19198929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]